Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile of NAFLD murine models (Part1 - NGS)

ABSTRACT: Gene expression profile of NAFLD murine models (Part1 - NGS)

PROVIDER: PRJEB73982 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12748000.fastq.gz	Fastqsanger.gz
	ERR12748100.fastq.gz	Fastqsanger.gz
	ERR12748200.fastq.gz	Fastqsanger.gz
	ERR12748300_1.fastq.gz	Fastqsanger.gz
	ERR12748300_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 960

Similar Datasets

Gene expression profile of NAFLD murine models (Part1 - NGS)

Project description:In this project, the gene expression profiles of commonly used murine models of NAFLD were compared to two publically available human datasets to assess proximity to human pathophysiology, focusing on differential expression and pathway enrichment. CCL4 was used as a positive control for fibrosis.

2024-03-18 | E-MTAB-12808 | biostudies-arrayexpress

Gene expression profile of NAFLD murine models (Part2 - Microarrays)

2024-03-18 | E-MTAB-12817 | biostudies-arrayexpress

Processed data related to "Gene expression profile of NAFLD murine models" (Part1: E-MTAB-12808, Part2: E-MTAB-12817)

Project description: Not available

| S-BSST1361 | biostudies-other

The effect of lncRNA PART1 knockdown on gene expression in HCC1806 and HCC1395 cells

Project description:PART1 was knocked down down using GapmeRs specific to PART1. The breast cancer cells used in this study were confirmed to have PART1 expression by qPCR and knockdown of PART was confirmed by qPCR.

2021-02-28 | GSE156114 | GEO

RNA sequencing of PART1 knockdown by siRNA in ovarian cancer cells

Project description:The expression of lncRNA PART1 was found to be significantly upregulated in platinum-sensitive patients with ovarian cancer, and this upregulation was positively correlated with a favorable prognosis. Cellular experiments demonstrated that inhibition of PART1 led to cellular senescence and increased resistance to cisplatin and PARP inhibitors. Thus, LncRNA PART1 is a novel target for overcoming resistance to PARP inhibitors in ovarian cancer.

2024-02-01 | GSE253450 | GEO

The effect of lncRNA PART1 knockdown on mature miRNA levels in HCC1806 and HCC1395 cells

2021-02-28 | GSE163569 | GEO

Sex-specific roles of PKLR in NAFLD using gain-of-function mouse models

Project description:The etiology of non-alcoholic fatty liver disease (NAFLD) is poorly understood, with males and Mexican population exhibiting markedly increased susceptibility. Using a systems genetics approach, involving multi-omic analysis of ~100 inbred strains, we recently identified several candidate genes driving NAFLD. We investigated the role of one of these candidates, liver pyruvate kinase (L-PK or Pklr) in NAFLD using patient samples and mouse models. We examined L-PK expression in mice of both sexes and in a cohort of bariatric surgery patients. We used liver-specific loss- and gain-of-function strategies in independent animal models of diet-induced steatosis and fibrosis, involving both sexes. Following treatment, we measured several metabolic phenotypes associated with obesity, insulin resistance, dyslipidemia, liver steatosis and fibrosis. Furthermore, liver tissues were used for gene expression and Western blots, and liver mitochondria for bioenergetics. Our results demonstrate that L-PK acts in a male-specific manner in the development of liver steatosis and fibrosis. Given that NAFLD/NASH exhibit sexual dimorphism, our results have important implications for the development of personalized therapeutics.

2021-01-19 | GSE157201 | GEO

Roles of PKLR in NAFLD using loss- and gain-of-function mouse models

Project description:The etiology of non-alcoholic fatty liver disease (NAFLD) is poorly understood, with males and Mexican population exhibiting markedly increased susceptibility. Using a systems genetics approach, involving multi-omic analysis of ~100 inbred strains, we recently identified several candidate genes driving NAFLD. We investigated the role of one of these candidates, liver pyruvate kinase (L-PK or Pklr) in NAFLD using patient samples and mouse models. We examined L-PK expression in mice of both sexes and in a cohort of bariatric surgery patients. We used liver-specific loss- and gain-of-function strategies in independent animal models of diet-induced steatosis and fibrosis, involving both sexes. Following treatment, we measured several metabolic phenotypes associated with obesity, insulin resistance, dyslipidemia, liver steatosis and fibrosis. Furthermore, liver tissues were used for gene expression and western blots, and liver mitochondria for bioenergetics. Our results demonstrate that L-PK acts in a male-specific manner in the development of liver steatosis and fibrosis. Given that NAFLD/NASH exhibit sexual dimorphism, our results have important implications for the development of personalized therapeutics.

2021-01-19 | GSE151182 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of lncRNA PART1 Regulated Transcriptomes

Project description:The goals of this study are to analyze the transcriptome profiling (RNA-seq) after lncRNA PART1 overexpression in MGC-803 cells.

2022-09-09 | GSE137074 | GEO

NAFLD model

Project description:NAFLD model

| PRJNA371560 | ENA